Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells. [PDF]
Al-Ashmawy GM +3 more
europepmc +1 more source
Proteomic footprint of serum urate concentration and urate transporter <i>ABCG2</i> dysfunctional polymorphism: a cross-sectional study. [PDF]
Ohashi Y +13 more
europepmc +1 more source
Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma. [PDF]
de Gooijer MC +11 more
europepmc +1 more source
Genome-wide association studies and traditional Chinese medicine in hyperuricemia: current evidence and mechanistic insights. [PDF]
Yang L, Liu J, Luo S, Deng Y.
europepmc +1 more source
KSQ-4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1-Mediated Multidrug Resistant Cancers. [PDF]
Yang Q +9 more
europepmc +1 more source
Research progress on the correlation between gut microbiota and the occurrence of hyperuricemia. [PDF]
Wang Q +5 more
europepmc +1 more source
SLC52A1 is a neofunctionalized primate urate transporter enabling intestinal urate secretion. [PDF]
Yamamoto S +23 more
europepmc +1 more source
FBP1 promotes ABCG2-mediated uric acid excretion through activation of the PI3K/AKT/CREB signaling pathway. [PDF]
Bai Q +7 more
europepmc +1 more source
Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors for Uricosuria. [PDF]
Bae E.
europepmc +1 more source

